KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $80.1 million.

  • West Pharmaceutical Services' Other Non-Current Assets rose 780.62% to $80.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $80.1 million, marking a year-over-year increase of 780.62%. This contributed to the annual value of $80.1 million for FY2025, which is 780.62% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Other Non-Current Assets of $80.1 million as of Q4 2025, which was up 780.62% from $75.8 million recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Other Non-Current Assets peaked at $80.1 million during Q4 2025, and registered a low of $19.0 million during Q1 2024.
  • Over the past 5 years, West Pharmaceutical Services' median Other Non-Current Assets value was $40.4 million (recorded in 2022), while the average stood at $47.5 million.
  • Per our database at Business Quant, West Pharmaceutical Services' Other Non-Current Assets tumbled by 4822.89% in 2024 and then soared by 26947.37% in 2025.
  • West Pharmaceutical Services' Other Non-Current Assets (Quarter) stood at $39.2 million in 2021, then fell by 2.04% to $38.4 million in 2022, then tumbled by 44.53% to $21.3 million in 2023, then skyrocketed by 248.83% to $74.3 million in 2024, then increased by 7.81% to $80.1 million in 2025.
  • Its Other Non-Current Assets was $80.1 million in Q4 2025, compared to $75.8 million in Q3 2025 and $70.5 million in Q2 2025.